Tencent

Tencent Holdings Limited, founded in 1998 and headquartered in Shenzhen, is a leading internet service provider that offers a diverse range of value-added services and online advertising solutions. The company operates through several segments, including Value-Added Services (VAS), FinTech and Business Services, and Online Advertising. Tencent is well-known for its popular communication and social platforms, such as WeChat and QQ, which facilitate user connectivity and provide various digital content and lifestyle services. In addition to social networking, Tencent engages in online gaming, cloud services, and the production and distribution of films and television programs. The company's extensive portfolio also includes software development, information technology services, and online entertainment. Tencent's strategic focus is on delivering comprehensive online services that cater to the diverse needs of internet users, solidifying its position as a significant player in the global digital landscape.

Leon Guo

Senior Vice President

Chi Ping Lau

President

Kennis Lau

Investor Relations Director

John Lo

Chief Financial Officer and Senior Vice President

Dan Xi

Senior Vice President

Daniel Xu

Co-Founder and Chief Information Officer

Andy Yu

Analyst, Investor Relations and Global Communications team

Past deals in ASIC

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company specializing in cloud computing and data processing solutions for data centers. Founded by Dr. Sunny Siu in 2020, the company develops data processing unit (DPU) chips aimed at enhancing the efficiency of data processing for its clients. Jaguar Microsystems offers products that feature accelerated Remote Direct Memory Access (RDMA) and RoCE, specifically designed for data center applications. The company targets domestic cloud service providers, telecommunications, and Internet service providers while also expanding its reach to meet the demands of the global market.

Immutable

Series C in 2022
Immutable Pty Ltd, founded in 2018 and based in Sydney, Australia, specializes in developing video games that leverage blockchain technology. The company focuses on creating scalable infrastructure that enhances in-game economies, promoting transparency and enabling player ownership of in-game assets. Immutable provides tools and services that allow players the freedom to trade and build their gaming experiences. Originally known as Fuel Games Pty Ltd, the company emphasizes empowering players by returning control over digital assets to them.

Guoxin Technology

Post in 2022
Suzhou Guoxin is an embedded CPU and SoC chip R&D and manufacturer. It has formed several series of C*Core embedded CPU cores with its own intellectual property rights, as well as SoC chip design platforms for different applications, which can be applied to information security, intelligent Power grid, financial security, e-government, industrial control, office automation and other fields.

Reask

Seed Round in 2022
Reask is a science and technology company that focuses on natural hazard modeling. Reask offers real-time, post-event, and longer-term AI solutions for global weather-related catastrophes by Global Risk mapping and probabilistic trend forecasting of catastrophe risk analytics.

Enflame

Series C in 2021
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.

XtalPi

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Atomwise

Series B in 2020
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.

Enflame

Series B in 2020
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.

Antstream Ltd

Series A in 2019
Antstream Arcade is a retro games streaming platform that offers over 1000 games for players to enjoy the old classics. Arcade, console or computer games can be played on online and across most devices. Enjoy the games in their original state or with a modern twist with our unique social challenges. Rise to the top of our global leaderboards, earn gems and bragging rights. Be the retro gaming champion on Antstream!

Enflame

Series A in 2019
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.

Enflame

Seed Round in 2018
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.

Atomwise

Series A in 2018
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.

XtalPi

Series B in 2018
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

AISEC

Corporate Round in 2018
Beijing Aisec Creative Technology Co., Ltd. designs and develops security software and hardware solutions for enterprises. The company offers products, such as AIScanner Security Detection System; providing scan web vulnerability and vulnerability, WebIDS; a web vulnerability detection and intrusion detection system, Intelligent Private Cloud WAF; an enterprise-level web application firewall, and Advanced Threat Analysis Platform; an advanced analysis and monitoring system. Beijing Aisec Creative Technology Co., Ltd. is based in Beijing, China.

XtalPi

Series A in 2015
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.